TRIM33 expression is decreased in renal cell carcinoma, and overexpression of TRIM33 in renal cell carcinoma can affect the proliferation, migration, and invasion of cancer cells by inhibiting the Wnt/β‐catenin pathway.27 Here, TRIM33 is linked to renal cell carcinoma.